Nishinomiya, Japan

Noboru Shigematsu

This inventor holds 1 USPTO granted patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1979.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noboru Shigematsu: Innovator in Hydroxyphenylglycine Compounds

Introduction

Noboru Shigematsu is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of chemistry, particularly in the synthesis of important pharmaceutical compounds. His work has implications for the development of antibiotics, which are crucial in modern medicine.

Latest Patents

Shigematsu holds a patent for a process for preparing a hydroxyphenylglycine compound. This patent involves the condensation of glyoxylic acid or a salt of glyoxylic acid, an ammonium salt of an organic or inorganic acid, and a phenol compound. The resulting hydroxyphenylglycine compounds are valuable intermediates in the synthesis of penicillins and cephalosporins, which are essential antibiotics.

Career Highlights

Noboru Shigematsu is associated with Tanabe Seiyaku Company, Limited, where he has contributed to various research initiatives. His innovative approach to chemical synthesis has led to advancements in pharmaceutical development. With a patent count of 1 patent, he continues to be an influential figure in his field.

Collaborations

Shigematsu has worked alongside notable colleagues such as Nobuhiko Ishihara and Masaru Senuma. Their collaborative efforts have furthered research and development in the pharmaceutical industry.

Conclusion

Noboru Shigematsu's contributions to the field of chemistry, particularly in the synthesis of hydroxyphenylglycine compounds, highlight his importance as an inventor. His work not only advances scientific knowledge but also plays a critical role in the development of life-saving medications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…